FDA.reportPublic FDA data

TENOFOVIR DISOPROXIL FUMARATE

Product NDC
50268-758
11-digit product format
502680758
Labeler code
50268
Product ID
50268-758_47fc8e5e-ba97-0118-e063-6394a90ad45c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
tenofovir disoproxil fumarate
Dosage form
TABLET
Route
ORAL
Labeler
AvPAK
Application
ANDA090742
Marketing category
ANDA
Marketing start
2020-03-30
Substance
TENOFOVIR DISOPROXIL FUMARATE
Active strength
300 mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
TENOFOVIR DISOPROXIL FUMARATE
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TENOFOVIR DISOPROXIL FUMARATE300 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiOTT9J7900I
Rxcui349251

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
33cd1557-9629-1a35-1f2f-499cf7c608bcProduct name220260305
5f93de8c-a439-4aaa-862f-7cf2524cb240Product name320250812
6286e356-28a5-4b4b-a174-76bf53b211e3Product name620250121
233e3f87-da6c-4b7d-80cb-963ca3258270Product name220240419
c0c98dbe-5e23-74e9-f9fc-07af05f77d95Product name820240319
4ef90d80-1289-4267-a2bb-01c741d1208fProduct name120230829
72dcca4e-6eae-4149-a92b-264c2a07004fProduct name120230808
1cd1fd33-94db-4c45-bd26-82773ea350a3Product name220220317
14397d46-1c8c-bbf7-f4b7-5a7e59d3690fProduct name420220314
320f244d-8b4e-4893-9f14-104b2a8e0aafProduct name220201007
7ff71f22-5b66-4a3d-bf64-671893a6409dProduct name220201007
6f122144-2ceb-48fa-a906-0d2eb742717eProduct name120190624
8051c8a3-aee0-45a2-a236-8ee3f9e65f67Product name120181211
a56d673d-fa42-4b0e-b5ce-e65a5eab34b7Product name120180911
d1784558-3c5f-4d73-8a7c-051102bb6c92Product name120160405
7fd46899-3505-4ed4-b856-6b2509a76004Product name120151123
0583b5e6-2e6e-c94b-9ff6-81a81ba199deProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50268-758-11TENOFOVIR DISOPROXIL FUMARATE1 in 1 BLISTER PACKTABLET14
50268-758-12TENOFOVIR DISOPROXIL FUMARATE20 in 1 BOXTABLET204

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50268-758-11EA - Each50268-758fb771ed3-0e04-4b54-afdd-d63dcfa4cd9212020-05-08
50268-758-12EA - Each50268-758f94d5f52-64f4-45fe-9737-c2e644d72d0812020-05-08

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50268-758TENOFOVIR DISOPROXIL FUMARATE TABLET [AVPAK]3Current NDC, Legacy NDC, 2 package rows20240110_a215f64c-84de-0649-e053-2a95a90a9d59.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
349251tenofovir disoproxil fumarate 300 MG Oral TabletPSNa215f64c-84de-0649-e053-2a95a90a9d594
349251tenofovir disoproxil fumarate 300 MG Oral TabletSCDa215f64c-84de-0649-e053-2a95a90a9d594
349251tenofovir disoproxil fumarate 300 MG (equivalent to tenofovir disoproxil 245 MG) Oral TabletSYa215f64c-84de-0649-e053-2a95a90a9d594

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50268-758-11502680758111 in 1 BLISTER PACKHistorical
50268-758-125026807581220 BLISTER PACK in 1 BOX (50268-758-12) / 1 TABLET in 1 BLISTER PACK (50268-758-11) 20 blister pack2020-03-300000-00-00NoNoCurrent